Literature DB >> 35413021

Categorizing Comorbid Risk for People Living With HIV: A Latent Profile Analysis.

Brianne Olivieri-Mui1,2, Sandra Shi2, Ellen P McCarthy2, Monty Montano3, Ira Wilson4, Gahee Oh2, Justin Manjourides1, Dae Hyun Kim2.   

Abstract

BACKGROUND: Categorizing clinical risk amidst heterogeneous multimorbidity in older people living with HIV/AIDS (PLWH) may help prioritize and optimize health care engagements.
METHODS: PLWH and their prevalent conditions in 8 health domains diagnosed before January 1, 2015 were identified using 2014-2016 Medicare claims and the Chronic Conditions Data Warehouse. Latent profile analysis identified 4 distinct clinical subgroups based on the likelihood of conditions occurring together [G1: healthy, G2: substance use (SU), G3: pulmonary (PULM), G4: cardiovascular conditions (CV)]. Restricted mean survival time regression estimated the association of each subgroup with the 365 day mean event-free days until death, first hospitalization, and nursing home admission. Zero-inflated Poisson regression estimated hospitalization frequency in 2-year follow-up.
RESULTS: Of 11,196 older PLWH, 71% were male, and the average age was 61 (SD 9.2) years. Compared with healthy group, SU group had a mean of 30 [95% confidence interval: (19.0 to 40.5)], PULM group had a mean of 28 (22.1 to 34.5), and CV group had a mean of 22 (15.0 to 22.0) fewer hospitalization-free days over 1 year. Compared with healthy group (2.8 deaths/100 person-years), CV group (8.4) had a mean of 4 (3.8 to 6.8) and PULM group (7.9) had a mean of 3 (0.7 to 5.5) fewer days alive; SU group (6.0) was not different. There was no difference in restricted mean survival time for nursing home admission. Compared with healthy group, SU group had 1.42-fold [95% confidence interval: (1.32 to 1.54)], PULM group had 1.71-fold (1.61 to 1.81), and CV group had 1.28-fold (1.20 to 1.37) higher rates of hospitalization.
CONCLUSION: Identifying clinically distinct subgroups with latent profile analysis may be useful to identify targets for interventions and health care optimization in older PLWH.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35413021      PMCID: PMC9248847          DOI: 10.1097/QAI.0000000000002999

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  23 in total

1.  A comparison of two approaches to measuring frailty in elderly people.

Authors:  Kenneth Rockwood; Melissa Andrew; Arnold Mitnitski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-07       Impact factor: 6.053

2.  Patterns of Substance Use and Arrest Histories Among Hospitalized HIV Drug Users: A Latent Class Analysis.

Authors:  Karen Shiu-Yee; Ahnalee M Brincks; Daniel J Feaster; Jemima A Frimpong; Ank Nijhawan; Raul N Mandler; Robert Schwartz; Carlos Del Rio; Lisa R Metsch
Journal:  AIDS Behav       Date:  2018-09

3.  Predicting Mortality and Adverse Outcomes: Comparing the Frailty Index to General Prognostic Indices.

Authors:  Sandra M Shi; Ellen P McCarthy; Susan L Mitchell; Dae Hyun Kim
Journal:  J Gen Intern Med       Date:  2020-02-18       Impact factor: 5.128

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  Latent Class Analysis for Developmental Research.

Authors:  Stephanie T Lanza
Journal:  Child Dev Perspect       Date:  2016-01-27

6.  Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian setting.

Authors:  Nadia Fairbairn; M-J Milloy; Ruth Zhang; Calvin Lai; Eric Grafstein; Thomas Kerr; Evan Wood
Journal:  J Emerg Med       Date:  2011-06-29       Impact factor: 1.484

7.  Patient and caregiver characteristics and nursing home placement in patients with dementia.

Authors:  Kristine Yaffe; Patrick Fox; Robert Newcomer; Laura Sands; Karla Lindquist; Kyle Dane; Kenneth E Covinsky
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

8.  HIV provider-patient communication regarding cardiovascular risk: results from the AIDS Treatment for Life International Survey.

Authors:  Renslow Sherer; Suniti Solomon; Mauro Schechter; Jean B Nachega; Jurgen Rockstroh; José M Zuniga
Journal:  J Int Assoc Provid AIDS Care       Date:  2014 Jul-Aug

9.  ESPACOMP Medication Adherence Reporting Guideline (EMERGE).

Authors:  Sabina De Geest; Leah L Zullig; Jacqueline Dunbar-Jacob; Remon Helmy; Dyfrig A Hughes; Ira B Wilson; Bernard Vrijens
Journal:  Ann Intern Med       Date:  2018-06-26       Impact factor: 51.598

10.  Perception of Patients With HIV/AIDS From Stigma and Discrimination.

Authors:  Mandana Saki; Sima Mohammad Khan Kermanshahi; Eesa Mohammadi; Minoo Mohraz
Journal:  Iran Red Crescent Med J       Date:  2015-06-23       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.